Agilent Technologies, Inc.
Harvard Bioscience’s (NASDAQ: HBIO) management announced on May 1, 2013, a plan to spin-off Harvard Apparatus Regenerative Technology (HART). The deal will occur after a failed attempt at an initial public offering earlier in the year for HART. HART is a loss incurring, high risk, high reward story, while Harvard Bioscience is steadily profitable. The losses from HART have contributed to flatish share performance for many years prior to more »
Agilent Technologies (NYSE: A) is one of my favorite stocks to watch because it is a potential fit for virtually any portfolio. When investing for the long term, diversification is the name of the game, and Agilent gives shareholders exposure to such industries as communications, electronics, life sciences, chemicals, and medical instruments. The company also looks pretty attractive on a valuation basis, with excellent earnings growth expected over the next more »
Warren Buffett famously said that, "It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price."
I think Waters Corporation (NYSE: WAT) is one such company and a classic Buffett 'buy and hold' investment.
Waters Corporation has been in business for 50 years and was founded by Jim Waters in 1958. It is the leading liquid chromatography (LC more »
Investing in electronics companies is relatively risky due to fluctuations in demand. But because I see the economy staying strong over the next several years, I think demand for these firms' technology will be long-lived.
Underneath those devices you are carrying comes a lot of testing and small parts. These stocks are behind the scenes, but are able to benefit from major breakthroughs in gadgetry. However, before buying just any more »
After divesting from Hewett-Packard in 1999, Agilent Technologies (NYSE: A) has rapidly expanded its reach and now has clients across the communications, life sciences, and chemical analysis sectors. The company manufacturers a wide variety of products including DNA microarrays, nuclear magnetic resonance, and vector network analysers. The products are often unique to individual customers, generating a strong bond between the company and its customers as only Agilent's engineers are more »
In his classic book, "Common Stocks And Uncommon Profits," Philip Fisher describes the attributes of a great investment, one that will return hundreds of percent in gains to its investors.
One of his main principles to look for in a winning stock is how much the prospective company spends on research and development (R&D). He explains that the only way an investor can realistically expect consistent gains over ten more »
Carrier Aggregation (CA) is one of the most fundamental and critical technologies used in cellular LTE-Advanced technology. Carrier Aggregation increases bandwidth and, thereby, increases bitrates. Recently, Carrier Aggregation achieved a few milestones, including the first complete network, SK Telecom, and the first smartphone, Samsung Galaxy S4 LTE-A. There were also other developments, such as the first public demonstration of LTE Carrier Aggregation at Mobile World Congress 2013, provided by Qualcomm more »
Agilent Technologies (NYSE: A) calls itself the world's premier measurement company. Providing bio-analytical and electronic measurement solutions to various industries, Agilent operates in four reportable segments.
These segments all provide tools that aid companies in analyzing the physical and biological properties of substances and products. The segments are distinguished more by customer base than services provided.
Aglient's four segments
Life sciences - Provides tools and services which enable customers more »
On April 15, Thermo fisher announced its acquisition of Life technologies (NASDAQ: LIFE) for $13.6 billion plus approximately $2.2 billion in net debt. This report analyzes the growth of Life technologies and concludes whether LIFE is over- or undervalued.
About Life Technologies
Life technologies produces systems and reagents that enable and simplify biological research within academic, clinical, and commercial research applications.
First Quarter results and outlook
Revenue for more »
Agilent Technologies (NYSE: A) reported its second quarter results showing adjusted net income that exceeded analysts’ estimates, but revenues that missed expectations.
For the current quarter Agilent has reported a non-GAAP net income of $269 million ($0.77 per share) compared to $222 million in the previous quarter and $275 million year-ago quarter. The non-GAAP income estimate reported does not include acquisition-related costs, cost of restructuring, amortization of more »
Billionaire Paul Tudor Jones (PTJ) has been all over the news after telling an audience of University of Virginia students and others that it's difficult for mothers to be successful traders given that their connection to a child is a focus "killer." PTJ has been one of the most successful traders over the past few decades, with a net worth of some $3.3 billion. Let's check out more »
Agilent Technologies (NYSE: A) is one of the leading manufacturers of measurement and testing instruments, and has exposure to many sectors, making it a great diversification play. With nicely growing revenues, a great balance sheet, and a share price that is still about 10% below its 52-week high despite the incredible rally in the markets, is Agilent worth a look?
About Agilent Technologies
Agilent Technologies, which was spun off from more »
Within the past 12 months, industrial equipment manufacturer Roper Industries (NYSE: ROP) has made two important acquisitions that have the potential to reorder the company's focus and boost its bottom-line earnings.
In mid-2012, Roper inked a $1.4 million cash purchase deal with privately held Sunquest Information Systems, an important player in the laboratory software industry. More recently, the company agreed to purchase privately held Managed Health Care Associates more »
After a long takeover battle, Thermo Fisher Scientific (NYSE: TMO) has agreed on a takeover deal with merger partner, Life Technologies (NASDAQ: LIFE). The cash-and-debt deal would cost roughly $13.6 billion and result in Thermo's assumption of over $2 billion in Life's debt.
This deal is notable for several reasons. Among other things, Thermo beat out a consortium of private equity firms with an apparently superior bid more »
Agilent Technologies (NYSE: A) is a highly diversified company, although almost half (48%) of its sales are generated by the Electronic Measurements Group (EMG). The recent reduction in this segment's sales led to a sell-off, providing an interesting entry point for long-term investors. I think that shares are expected to perform well based on three key reasons.
Good position to benefit from an economic recovery
Agilent largely relies on more »
The big news in the medical service and device sector is the speculated buyout of Life Technologies (NASDAQ: LIFE). However, I believe investors could snatch up Agilent Technologies (NYSE: A) for a "good" price amid the hype surrounding Life.Agilent provides bio-analytic and electronic measurement solutions to the communications, electronics, life sciences and chemical analysis industries, meaning it has a bit more of a diversified portfolio, serving not only the more »
Since the beginning of the year, shareholders of Life Technologies (NASDAQ: LIFE) must be quite happy as its share price advanced significantly, from $49 per share to nearly $67 per share, a four-month gain of 36.7%. Recently, the company received a bid of $65 per share from a buyout group, which includes Blackstone Group, Carlyle Group, KKR & Co, and Temasek Holdings. However, Thermo Fisher Scientific (NYSE: TMO) placed a more »
With the markets recovering since early 2013 there are certain companies who share you must closely watch or a wide to generate considerable amounts of profits on the New York Stock Exchange and NASDAQ. The stocks that you must carefully watch include the stocks of Agilent Technologies Inc (NYSE: A), B&G Foods Inc (NYSE: BGS), Qlik Technologies Inc (NASDAQ: QLIK), Ellie Mae Inc (NYSE: ELLI) and LogMeIn Inc (NASDAQ more »
Innovation coupled with high returns on investment is what our analysts smell for the near future. With a revenue of $1.84 billion in 2012, Waters Corporation (NYSE: WAT), an analytical instrument manufacturer, is driving scientific discovery and operational excellence for customers worldwide. The company, founded in 1958 is based in Milford, Massachusetts and operates in two segments: Waters Division & TA Division. Through its Waters Division, the company designs, manufactures more »
A SWOT analysis is a look at a company’s strengths, weaknesses, opportunities, and threats, and is a tremendous way to gain a detailed and thorough perspective on a company and its future. As 2013 begins, I would like to focus on a diversified science and technology giant: Danaher Corporation (NYSE: DHR).
- Solid Revenue Growth: In 2007, Danaher reported revenue of $11.03 billion; in 2012, the company announced more »
- Page 1 of 2